Unknown NA INTERVENTIONAL 1-arm NCT00868829

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial (FOCUS)

Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd.

Interventions Firebird2

Updated 6 times since 2017 Last updated: Aug 9, 2011 Started: Apr 30, 2009 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00868829, this NA trial focuses on Coronary Heart Disease and remains ongoing. Sponsored by Shanghai MicroPort Medical (Group) Co., Ltd., it has been updated 6 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Feb 2017 — Jun 2018 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai MicroPort Medical (Group) Co., Ltd.

Data source: Shanghai MicroPort Medical (Group) Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China